Literature DB >> 23355200

Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.

Jeffrey Wu1, Peiguo G Chu, Zhong Jiang, Sean K Lau.   

Abstract

Immunohistochemical expression of napsin A in primary pulmonary mucinous tumors is not well established. Napsin A immunoreactivity was evaluated in 43 mucin-producing adenocarcinomas of the lung consisting of 18 tumors formerly classified as mucinous bronchioloalveolar carcinoma, 15 colloid adenocarcinomas, 5 solid predominant adenocarcinomas with mucin production, and 5 adenocarcinomas with signet ring cell features, as well as in 25 extrapulmonary mucinous adenocarcinomas of different anatomic sites. Immunohistochemical expression of thyroid transcription factor 1 (TTF-1) was also compared. Thirty-three percent of mucinous lung tumors exhibited positive immunoreactivity for napsin A, whereas 42% expressed TTF-1. All 25 extrapulmonary mucinous adenocarcinomas lacked expression of napsin A and TTF-1. Mucin-producing neoplasms of the lung infrequently express napsin A, suggesting that immunohistochemical assessment of napsin A may have limited diagnostic usefulness for distinguishing primary and metastatic mucinous adenocarcinomas involving the lung.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355200     DOI: 10.1309/AJCP62WJUAMSZCOM

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.

Authors:  Lauren L Ritterhouse; Marina Vivero; Mari Mino-Kenudson; Lynette M Sholl; A John Iafrate; Valentina Nardi; Fei Dong
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Clinical diagnosis and detection of genetic mutations of pancreatic metastases: A report of four cases and review of the literature.

Authors:  Ye Li; Zixiang Zhang; Yi Zhang; Jian Yang; Dongming Zhu; Dechun Li; Jian Zhou
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

3.  KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.

Authors:  Alyssa M Krasinskas; Simon I Chiosea; Timothy Pal; Sanja Dacic
Journal:  Mod Pathol       Date:  2013-07-26       Impact factor: 7.842

Review 4.  Biology of invasive mucinous adenocarcinoma of the lung.

Authors:  Yoon Jin Cha; Hyo Sup Shim
Journal:  Transl Lung Cancer Res       Date:  2017-10

5.  Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.

Authors:  Yang Qu; Dan Zhao; Jing Mu; Nanying Che; Chen Zhang; Zichen Liu; Dan Su; Lijuan Zhou; Haiqing Zhang; Lixin Wei
Journal:  Tumour Biol       Date:  2015-08-09

6.  Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma.

Authors:  Angelica Sonzogni; Fabrizio Bianchi; Alessandra Fabbri; Mara Cossa; Giulio Rossi; Alberto Cavazza; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Benedetta Picciani; Barbara Valeri; Ugo Pastorino; Giuseppe Pelosi
Journal:  J Pathol Clin Res       Date:  2017-03-22

7.  Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung.

Authors:  Mingxia Shi; Hongzhi Xu; Angela DiPoto Brahmbhatt; Eduardo Gonzalez-Toledo; Maria-Magdalena Georgescu
Journal:  Am J Case Rep       Date:  2018-01-26

Review 8.  Invasive mucinous adenocarcinoma of the lung.

Authors:  Lu Xu; Chenghui Li; Hongyang Lu
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

9.  Napsin A Expression in Human Tumors and Normal Tissues.

Authors:  Sören Weidemann; Jan Lukas Böhle; Hendrina Contreras; Andreas M Luebke; Martina Kluth; Franziska Büscheck; Claudia Hube-Magg; Doris Höflmayer; Katharina Möller; Christoph Fraune; Christian Bernreuther; Michael Rink; Ronald Simon; Anne Menz; Andrea Hinsch; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Eike Burandt; Rainer Krech; David Dum; Till Krech; Andreas Marx; Sarah Minner
Journal:  Pathol Oncol Res       Date:  2021-04-20       Impact factor: 3.201

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.